Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Hold
400,000
1.76% 18
2026
Q1
$1.64M Buy
400,000
+150,000
+60% +$727K 1.37% 25
2025
Q4
$1.66M Hold
250,000
1.4% 23
2025
Q3
$1.53M Buy
250,000
+75,000
+43% +$585K 1.28% 30
2025
Q2
$1.61M Buy
175,000
+25,000
+17% +$256K 1.47% 27
2025
Q1
$1.8M Hold
150,000
1.81% 25
2024
Q4
$1.66M Hold
150,000
1.48% 31
2024
Q3
$2.43M Hold
150,000
1.94% 18
2024
Q2
$1.63M Hold
150,000
1.49% 27
2024
Q1
$2.1M Hold
150,000
1.76% 21
2023
Q4
$1.58M Hold
150,000
1.27% 28
2023
Q3
$1.37M Buy
150,000
+75,000
+100% +$673K 1.45% 23
2023
Q2
$545K Buy
+75,000
New +$647K 0.53% 52
2021
Q1
Sell
-46,620
Closed -$157K 88
2020
Q4
$157K Buy
+46,620
New +$175K 0.15% 80

Other funds holding EOLS

CM Management's EOLS Position: Q2 2026 in Review

CM Management held its Evolus (EOLS) position steady in Q2 2026 at 400,000 shares worth $2.78M. The position accounts for 1.76% of the portfolio, ranked #18.

CM Management first reported a position in EOLS in Q4 2020 and has held it in 14 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • CM Management held 400,000 shares of Evolus worth $2.78M as of Q2 2026.
  • CM Management left its Evolus share count unchanged in Q2 2026.
  • Evolus made up 1.76% of CM Management's portfolio in Q2 2026, its #18 holding.
  • CM Management first reported a position in Evolus in Q4 2020 and has held it in 14 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.